Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Qian Xu, Zaiping Zhang, Zhiming Chen, Biying Zhang, Chanyuan Zhao, Yimin Zhang, Conghui Zhao, Xiaodong Deng, Yao Zhou, Yanyun Wu & Jiang Gu. (2019) Nonspecific immunoglobulin G is effective in preventing and treating cancer in mice. Cancer Management and Research 11, pages 2073-2085.
Read now
Read now
Anne S De Groot. (2013) Do Tregitopes have the potential to impact the current treatment landscape of autoimmune diseases?. Expert Review of Clinical Immunology 9:12, pages 1155-1157.
Read now
Read now
Arti Nanda. (2009) How effective are intravenous immunoglobulins in pediatric dermatology?. Expert Review of Dermatology 4:1, pages 37-45.
Read now
Read now
Uriel Katz, Irena Kishner, David Magalashvili, Yehuda Shoenfeld & Anat Achiron. (2006) Long term safety of IVIg therapy in multiple sclerosis: 10 years experience. Autoimmunity 39:6, pages 513-517.
Read now
Read now
Articles from other publishers (57)
Denise Calaprice-Whitty, Angela TangJanice Tona. (2023) Factors Associated with Symptom Persistence in PANS: Part II—Presenting Features, Medical Comorbidities, and IVIG Treatment History. Journal of Child and Adolescent Psychopharmacology 33:9, pages 365-377.
Crossref
Crossref
Maria Giovanna Danieli, Eleonora Antonelli, Stefania Auria, Elena Buti & Yehuda Shoenfeld. (2023) Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions. Autoimmunity Reviews 22:11, pages 103451.
Crossref
Crossref
Tsvetelina Velikova, Metodija Sekulovski, Simona Bogdanova, Georgi Vasilev, Monika Peshevska-Sekulovska, Dimitrina Miteva & Tsvetoslav Georgiev. (2023) Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine. Antibodies 12:1, pages 20.
Crossref
Crossref
Irena Pintea, Ioana Adriana Muntean, Carmen Teodora Dobrican, Nicolae Miron & Diana Deleanu. (2022) Off-Label Benralizumab in Severe Non-Necrotizing Eosinophilic Vasculitis following Critical COVID-19 Disease and in DRESS. Journal of Clinical Medicine 11:22, pages 6642.
Crossref
Crossref
Jorge Adrian Masso-Silva, George Sakoulas, Jarod Olay, Victoria Groysberg, Matthew Geriak, Victor Nizet, Laura E. Crotty Alexander & Angela Meier. (2022) Abrogation of neutrophil inflammatory pathways and potential reduction of neutrophil-related factors in COVID-19 by intravenous immunoglobulin. Frontiers in Immunology 13.
Crossref
Crossref
Allison Hanaford & Simon C. Johnson. (2022) The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence. Orphanet Journal of Rare Diseases 17:1.
Crossref
Crossref
Viktoriya Boncheva, Michael Linnebacher, Said Kdimati, Hannah Draper, Laurence Orchard, Ken Mills, Gerald O’Sullivan, Mark Tangney & Barbara-ann Guinn. (2022) Identification of the Antigens Recognised by Colorectal Cancer Patients Using Sera from Patients Who Exhibit a Crohn’s-like Lymphoid Reaction. Biomolecules 12:8, pages 1058.
Crossref
Crossref
Lara Filipa Mendes de Morais Baptista & Darren Kelly. (2022) Use of human intravenous immunoglobulin for treatment of immune‐mediated haemolytic anaemia in two cats. Veterinary Record Case Reports 10:2.
Crossref
Crossref
Sanli Movafaghi, Hao Wu, Irene M. Francino Urdániz, David S. Bull, Mary D. Kelly, Theodore W. Randolph & Andrew P. Goodwin. (2020) The Effect of Container Surface Passivation on Aggregation of Intravenous Immunoglobulin Induced by Mechanical Shock. Biotechnology Journal 15:9, pages 2000096.
Crossref
Crossref
Eva Hadaschik, Rüdiger Eming, Lars E. French, Giampiero Girolomoni, Michael Hertl, Stephen Jolles, Sarolta Karpati, Kerstin Steinbrink, Georg Stingl, Beatrix Volc-Platzer, Detlef Zillikens & Alexander Enk. (2020) Europäische Leitlinien (S1) für die Verwendung von hoch dosierten intravenösen Immunglobulinen in der DermatologieEuropean Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology. Der Hautarzt 71:7, pages 542-552.
Crossref
Crossref
Cristina Tarango & Joseph S. Palumbo. (2019) Antiphospholipid syndrome in pediatric patients. Current Opinion in Hematology, pages 1.
Crossref
Crossref
João Pedro Gomes, Lèlita Santos & Yehuda Shoenfeld. (2019) Intravenous immunoglobulin (IVIG) in the vanguard therapy of Systemic Sclerosis. Clinical Immunology 199, pages 25-28.
Crossref
Crossref
Arpad Barabas, Chad Cole, Zoltan Kovacs, Erno Kovacs & Rene Lafreniere. (2018) The Modified Vaccination Technique. Vaccines 7:1, pages 1.
Crossref
Crossref
Sara Tenti, Marta Fabbroni, Virginia Mancini, Filomena Russo, Mauro Galeazzi & Antonella Fioravanti. (2018) Intravenous Immunoglobulins as a new opportunity to treat discoid lupus erythematosus. Autoimmunity Reviews 17:8, pages 791-795.
Crossref
Crossref
. (2018) Immunoglobulin Therapy in Infertile Women: Safety and Tolerance. International Journal of Women’s Health Care 3:1.
Crossref
Crossref
Shuayb Elkhalifa, Siddiq Anwar & Yousuf Karim. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences
1
11
.
A Watad, H Amital & Y Shoenfeld. (2017) Intravenous immunoglobulin: a biological corticosteroid-sparing agent in some autoimmune conditions. Lupus 26:10, pages 1015-1022.
Crossref
Crossref
F El Hilali, H El Hilali, MF Belahsen, A El Idrissi & H Mazouz. (2017) Uses of Intravenous Immunoglobulin: A 13-Year Evaluation of Guillain–Barré Syndrome in Fez, Morocco. Journal of Biology and Medicine 1:1, pages 001-005.
Crossref
Crossref
Alexander Enk, Eva Hadaschik, Rüdiger Eming, Gerhard Fierlbeck, Lars French, Giampiero Girolomoni, Michael Hertl, Stephen Jolles, Sarolta Karpati, Kerstin Steinbrink, Georg Stingl, Beatrix Volc‐Platzer & Detlef Zillikens. (2017) Europäische Leitlinien (S1) für die Anwendung von hochdosierten intravenösen Immunglobulinen in der Dermatologie. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 15:2, pages 227-238.
Crossref
Crossref
Alexander Enk, Eva Hadaschik, Rüdiger Eming, Gerhard Fierlbeck, Lars French, Giampiero Girolomoni, Michael Hertl, Stephen Jolles, Sarolta Karpati, Kerstin Steinbrink, Georg Stingl, Beatrix Volc‐Platzer & Detlef Zillikens. (2016) European Guidelines (S1) on the use of high‐dose intravenous immunoglobulin in dermatology. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 15:2, pages 228-241.
Crossref
Crossref
A.H. Enk, E.N. Hadaschik, R. Eming, G. Fierlbeck, L.E. French, G. Girolomoni, M. Hertl, S. Jolles, S. Karpati, K. Steinbrink, G. Stingl, B. Volc-Platzer & D. Zillikens. (2016) European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology. Journal of the European Academy of Dermatology and Venereology 30:10, pages 1657-1669.
Crossref
Crossref
Jawad Bilal, Irbaz B. Riaz, Jennifer L. Hill & Tirdad T. Zangeneh. (2016) Intravenous Immunoglobulin–Induced Pulmonary Embolism: It Is Time to Act!. American Journal of Therapeutics 23:4, pages e1074-e1077.
Crossref
Crossref
Nayef M. Kazzaz, W. Joseph McCune & Jason S. Knight. (2016) Treatment of catastrophic antiphospholipid syndrome. Current Opinion in Rheumatology 28:3, pages 218-227.
Crossref
Crossref
Yumiko Nakano, Takeshi Hayashi, Kentaro Deguchi, Kota Sato, Nozomi Hishikawa, Toru Yamashita, Yasuyuki Ohta, Yoshiki Takao, Tomohiro Morio & Koji Abe. (2016) Two young stroke patients associated with regular intravenous immunoglobulin (IVIg) therapy. Journal of the Neurological Sciences 361, pages 9-12.
Crossref
Crossref
Wataru YAMAMOTO, Yasuhiro ITANO, Tsunefumi KOBAYASHI, Daishiro MIURA & Yoshinori KASAHARA. (2016) Prophylactic treatment with sulphonated immunoglobulin G attenuates development of mechanical allodynia-like response in mice with neuropathic pain. Journal of Veterinary Medical Science 78:1, pages 77-82.
Crossref
Crossref
Giacomo Maria Guidelli, Sara Tenti, Nicola Antonio Pascarelli, Mauro Galeazzi & Antonella Fioravanti. (2015) Granulomatosis with polyangiitis and intravenous immunoglobulins: A case series and review of the literature. Autoimmunity Reviews 14:8, pages 659-664.
Crossref
Crossref
M H Ravindranath, P I Terasaki, C Y Maehara, V Jucaud, S Kawakita, T Pham & W Yamashita. (2015) Immunoglobulin (Ig)G purified from human sera mirrors intravenous Ig human leucocyte antigen (HLA) reactivity and recognizes one's own HLA types, but may be masked by Fab complementarity-determining region peptide in the native sera. Clinical and Experimental Immunology 179:2, pages 309-328.
Crossref
Crossref
Alejandro López-Requena, Oscar R. Burrone & Rolando Pérez. 2014. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies
407
434
.
L. Darnige & A. Lillo-Le Louët. (2014) Traitements par immunoglobulines et complications thrombotiques. La Revue de Médecine Interne 35:1, pages 39-44.
Crossref
Crossref
Mir Hadi Jazayeri, Ali Akbar Pourfathollah, Mohammad Javad Rasaee, Zahra Porpak & Mohammad Ebrahim Jafari. (2013) The concentration of total serum IgG and IgM in sera of healthy individuals varies at different age intervals. Biomedicine & Aging Pathology 3:4, pages 241-245.
Crossref
Crossref
Leslie P. Cousens, Ryan Tassone, Bruce D. Mazer, Vasanthi Ramachandiran, David W. Scott & Anne S. De Groot. (2013) Tregitope update: Mechanism of action parallels IVIg. Autoimmunity Reviews 12:3, pages 436-443.
Crossref
Crossref
Gisele Zandman-Goddard, Alexander Krauthammer, Yair Levy, Pnina Langevitz & Yehuda Shoenfeld. (2011) Long-Term Therapy with Intravenous Immunoglobulin is Beneficial in Patients with Autoimmune Diseases. Clinical Reviews in Allergy & Immunology 42:2, pages 247-255.
Crossref
Crossref
S. Wymann, A. W. Zuercher, A. Schaub, R. Bolli, B. M. Stadler & S. M. Miescher. (2011) Monomeric and Dimeric IgG Fractions Show Differential Reactivity Against Pathogen‐Derived Antigens. Scandinavian Journal of Immunology 74:1, pages 31-41.
Crossref
Crossref
Sara M. Trucco, Edgar Jaeggi, Bettina Cuneo, Anita J. Moon-Grady, Earl Silverman, Norman Silverman & Lisa K. Hornberger. (2011) Use of Intravenous Gamma Globulin and Corticosteroids in the Treatment of Maternal Autoantibody-Mediated Cardiomyopathy. Journal of the American College of Cardiology 57:6, pages 715-723.
Crossref
Crossref
Wassim Elyaman, Samia J. Khoury, David W. Scott & Anne S. De Groot. (2011) Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis. Neurology Research International 2011, pages 1-6.
Crossref
Crossref
Caterina De Carolis, Carlo Perricone & Roberto Perricone. (2009) NK Cells, Autoantibodies, and Immunologic Infertility: A Complex Interplay. Clinical Reviews in Allergy & Immunology 39:3, pages 166-175.
Crossref
Crossref
Yoav Arnson, Yehuda Shoenfeld, Eisen Alon & Howard Amital. (2010) The Antiphospholipid Syndrome as a Neurological Disease. Seminars in Arthritis and Rheumatism 40:2, pages 97-108.
Crossref
Crossref
Ana Elisabete Pires, Ana Filipa Afonso, Ana Queirós, Maria Salomé Cabral, Luis Porrata, Svetomir N. Markovic, Srini V. Kaveri, Maria Gomes da Silva & Cristina João. (2010) Treatment With Polyclonal Immunoglobulin During T-cell Reconstitution Promotes Naive T-cell Proliferation. Journal of Immunotherapy 33:6, pages 618-625.
Crossref
Crossref
Cannon Milani, Samir M Dalia & Gerald A Colvin. (2009) Thromboembolic complications of intravenous immunoglobulin (IVIG) in an immunocompromised patient with Chronic Lymphocytic Leukemia: a case report. Cases Journal 2:1.
Crossref
Crossref
Sonia Néron, Gilles Boire, Nathalie Dussault, Claudia Racine, Artur J. de Brum-Fernandes, Serge Côté & Annie Jacques. (2009) CD40-activated B cells from patients with systemic lupus erythematosus can be modulated by therapeutic immunoglobulins in vitro. Archivum Immunologiae et Therapiae Experimentalis 57:6, pages 447-458.
Crossref
Crossref
Beatrix KotlanDavid F Stroncek & Francesco M Marincola. (2009) Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science. Immunotherapy 1:6, pages 995-1015.
Crossref
Crossref
G Zandman-Goddard, M Blank & Y Shoenfeld. (2009) Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside. Lupus 18:10, pages 884-888.
Crossref
Crossref
Alexander Enk, Gerhard Fierlbeck, Lars French, Michael Hertl, Gerald Messer, Michael Meurer, Kerstin Steinbrink, Georg Stingl, Beatrice Volc-Platzer & Detlef Zillikens. (2009) Use of high-dose immunoglobulins in dermatology. Journal der Deutschen Dermatologischen Gesellschaft 7:9, pages 806-812.
Crossref
Crossref
N. Dussault, E. Ducas, C. Racine, A. Jacques, I. Pare, S. Cote & S. Neron. (2008) Immunomodulation of human B cells following treatment with intravenous immunoglobulins involves increased phosphorylation of extracellular signal-regulated kinases 1 and 2. International Immunology 20:11, pages 1369-1379.
Crossref
Crossref
Sandra Wymann, Marco Ghielmetti, Alexander Schaub, Michael J. Baumann, Beda M. Stadler, Reinhard Bolli & Sylvia M. Miescher. (2008) Monomerization of dimeric IgG of intravenous immunoglobulin (IVIg) increases the antibody reactivity against intracellular antigens. Molecular Immunology 45:9, pages 2621-2628.
Crossref
Crossref
Fu-Nan Cho & Cheng-Bin Liu. (2008) Potential Role of Intravenous Immunoglobulin in the Management of Peripartum Maternal Thrombocytopenia Due to Various Causes. Journal of the Chinese Medical Association 71:5, pages 267-269.
Crossref
Crossref
Amal EphremSouleima ChamatCatherine MiquelSylvain FissonLuc MouthonGiuseppina CaligiuriSandrine DelignatSriramulu ElluruJagadeesh BayrySebastien Lacroix-DesmazesJosé L. Cohen, Benoît L. Salomon, Michel D. KazatchkineSrini V. KaveriNamita Misra. (2008) Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood 111:2, pages 715-722.
Crossref
Crossref
K. Kobayashi, K. Tada, H. Itabe, T. Ueno, P.-H. Liu, A. Tsutsumi, M. Kuwana, T. Yasuda, Y. Shoenfeld, P.G. de Groot & E. Matsuura. (2007) Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages. Lupus 16:12, pages 929-938.
Crossref
Crossref
Christos E. Lampropoulos, Graham R. V. Hughes & David P. D’ Cruz. (2006) Intravenous immunoglobulin in the treatment of resistant subacute cutaneous lupus erythematosus: a possible alternative. Clinical Rheumatology 26:6, pages 981-983.
Crossref
Crossref
Uriel Katz, Anat Achiron, Yaniv Sherer & Yehuda Shoenfeld. (2007) Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmunity Reviews 6:4, pages 257-259.
Crossref
Crossref
Irina Buhaescu, Adrian Covic & Gilbert Deray. (2007) Treatment of Proliferative Lupus Nephritis—A Critical Approach. Seminars in Arthritis and Rheumatism 36:4, pages 224-237.
Crossref
Crossref
Alan D. Salama. 2007. The Kidney in Systemic Autoimmune Diseases. The Kidney in Systemic Autoimmune Diseases
107
119
.
I. Marie, G. Maurey, F. Herve, M-F. Hellot & H. Levesque. (2006) Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature. British Journal of Dermatology 155:4, pages 714-721.
Crossref
Crossref
I. MARIE, F. HERVE, L. LAHAXE, S. ROBADAY, E. GERARDIN & H. LEVESQUE. (2006) Intravenous immunoglobulin-associated cranial pachymeningitis. Journal of Internal Medicine 260:2, pages 164-167.
Crossref
Crossref
Sinuhe Hahn, Anurag Kumar Gupta, Carolyn Troeger, Corinne Rusterholz & Wolfgang Holzgreve. (2006) Disturbances in placental immunology: ready for therapeutic interventions?. Springer Seminars in Immunopathology 27:4, pages 477-493.
Crossref
Crossref
Roberto Perricone, Gioia Di Muzio, Carlo Perricone, Roberto Giacomelli, Domenico De Nardo, Luigi Fontana & Caterina De Carolis. (2006) High Levels of Peripheral Blood NK Cells in Women Suffering from Recurrent Spontaneous Abortion are Reverted from High-Dose Intravenous Immunoglobulins. American Journal of Reproductive Immunology 55:3, pages 232-239.
Crossref
Crossref
KELLI ROSENTHAL. (2005) A jump start for the immune system. Nursing Made Incredibly Easy! 3:6, pages 10-13.
Crossref
Crossref